Terms: = Ovarian cancer AND NCOA4, RP11-481A12_4, 8031, ENSG00000138293, PTC3, ELE1, Q13772, RFG, DKFZp762E1112, ARA70
24026 results:
1. Tumorigenic role of Pak4 in ovarian cancer and its correlation with immune infiltration.
Tang L; Ye H; Chen L; Dong W; Hu X; Yu L
BMC Med Genomics; 2024 May; 17(1):148. PubMed ID: 38807162
[TBL] [Abstract] [Full Text] [Related]
2. Epithelial ovarian cancer and brain metastases: might the
Sassu CM; Marchetti C; Russo G; Minucci A; Boccia SM; Benato A; Nero C; Piermattei A; Mattogno PP; Giannarelli D; Ferrandina G; Olivi A; Fagotti A; Scambia G
Int J Gynecol Cancer; 2024 Jan; 34(1):88-98. PubMed ID: 38805344
[TBL] [Abstract] [Full Text] [Related]
3. The Impact of Mitochondria in ovarian cancer Cell Metabolism, Proliferation, and Metastasis.
Schatten H
Adv Exp Med Biol; 2024; 1452():119-125. PubMed ID: 38805128
[TBL] [Abstract] [Full Text] [Related]
4. Tubulin Complexity in cancer and Metastasis.
Danziger M; Xu F; Noble H; Yang P; Roque DM
Adv Exp Med Biol; 2024; 1452():21-35. PubMed ID: 38805123
[TBL] [Abstract] [Full Text] [Related]
5. [Analysis of sequential chemotherapy efficacy in ovarian epithelial carcinoma, fallopian tube carcinoma and primary peritoneal carcinoma].
Shen XY; Li XP; Wang Y; Wu Y; Li Y; Yang YC; Wei LH; Fan Y; Tang ZQ
Zhonghua Fu Chan Ke Za Zhi; 2024 May; 59(5):383-390. PubMed ID: 38797568
[No Abstract] [Full Text] [Related]
6. Anticancer Effects of the Novel Pyrazolyl-Urea GeGe-3.
Williams A; Cooper E; Clark B; Perry L; Ponassi M; Iervasi E; Brullo C; Greenhough A; Ladomery M
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791418
[TBL] [Abstract] [Full Text] [Related]
7. Uncovering miRNA-mRNA Regulatory Networks Related to Olaparib Resistance and Resensitization of
Biegała Ł; Kołat D; Gajek A; Płuciennik E; Marczak A; Śliwińska A; Mikula M; Rogalska A
Cells; 2024 May; 13(10):. PubMed ID: 38786089
[TBL] [Abstract] [Full Text] [Related]
8. Phosphoproteomics Reveals Selective Regulation of Signaling Pathways by Lysophosphatidic Acid Species in Macrophages.
Dietze R; Szymanski W; Ojasalu K; Finkernagel F; Nist A; Stiewe T; Graumann J; Müller R
Cells; 2024 May; 13(10):. PubMed ID: 38786034
[TBL] [Abstract] [Full Text] [Related]
9. Analysis of prognostic value of lactate metabolism-related genes in ovarian cancer based on bioinformatics.
Sun J; Feng Q; Xu Y; Liu P; Wu Y
J Ovarian Res; 2024 May; 17(1):110. PubMed ID: 38778371
[TBL] [Abstract] [Full Text] [Related]
10. Synchronous skull base and spinal metastases in a patient with treatment-resistant, high-grade serous adenocarcinoma of tubo-ovarian origin.
Ziegler J; El-Shakankery KH; Hyare H; Flynn M
BMJ Case Rep; 2024 May; 17(5):. PubMed ID: 38772871
[TBL] [Abstract] [Full Text] [Related]
11. Racial and Ethnic Inequities in cancer Care Continuity During the COVID-19 Pandemic Among Those With SARS-CoV-2.
Islam JY; Hathaway CA; Hume E; Turner K; Hallanger-Johnson J; Tworoger SS; Camacho-Rivera M
JAMA Netw Open; 2024 May; 7(5):e2412050. PubMed ID: 38767916
[TBL] [Abstract] [Full Text] [Related]
12. Mirvetuximab soravtansine: A breakthrough in targeted therapy for platinum-resistant ovarian cancer.
Kokori E; Olatunji G; Komolafe R; Abraham IC; Ukoaka B; Samuel O; Ayodeji A; Ogunbowale I; Ezenwoba C; Aderinto N
Medicine (Baltimore); 2024 May; 103(20):e38132. PubMed ID: 38758856
[TBL] [Abstract] [Full Text] [Related]
13. Exploratory biomarker analysis in the phase III L-MOCA study of olaparib maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer.
Li H; Peng Z; Zhu J; Zhao W; Huang Y; An R; Zheng H; Qu P; Wang L; Zhou Q; Wang D; Lou G; Wang J; Wang K; Kong B; Xie X; Yin R; Low J; Rozita AM; Sen LC; Meng YC; Kiong KS; Liu J; Liang Z; Lv W; Zhu Y; Hu W; Sun W; Su J; Wang Q; Zang R; Ma D; Gao Q
BMC Med; 2024 May; 22(1):199. PubMed ID: 38755585
[TBL] [Abstract] [Full Text] [Related]
14. Niraparib, Dostarlimab, and Bevacizumab as Combination Therapy in Pretreated, Advanced Platinum-Resistant ovarian cancer: Findings From Cohort A of the OPAL Phase II Trial.
Liu JF; Gaillard S; Wahner Hendrickson AE; Yeku O; Diver E; Gunderson Jackson C; Arend R; Ratner E; Samnotra V; Gupta D; Chung J; Zhang H; Compton N; Baines A; Bacqué E; Liu X; Felicetti B; Konecny GE
JCO Precis Oncol; 2024 May; 8():e2300693. PubMed ID: 38754056
[TBL] [Abstract] [Full Text] [Related]
15. The Role of Palliative Surgery in the Management of Acute Intestinal Obstruction Secondary to Peritoneal Carcinomatosis.
Bhat BK; Yadav A; Nundy S
Chirurgia (Bucur); 2024 Apr; 119(2):218-226. PubMed ID: 38743835
[No Abstract] [Full Text] [Related]
16. [Impact of changes in malignant tumor death spectrum on life expectancy in Tianjin residents from 1999-2019].
Jiang TT; Wang SY; Yin XL; Xu JH; Wang DZ
Zhonghua Zhong Liu Za Zhi; 2024 May; 46(5):461-470. PubMed ID: 38742360
[No Abstract] [Full Text] [Related]
17. Transcript and protein signatures derived from shared molecular interactions across cancers are associated with mortality.
Zhao Y; Li X; Loscalzo J; Smelik M; Sysoev O; Wang Y; Mahmud AKMF; Mansour Aly D; Benson M
J Transl Med; 2024 May; 22(1):444. PubMed ID: 38734658
[TBL] [Abstract] [Full Text] [Related]
18. Vitamins in Gynecologic Malignancies.
Wierzbowska N; Olszowski T; Chlubek D; Kozłowski M; Cymbaluk-Płoska A
Nutrients; 2024 May; 16(9):. PubMed ID: 38732639
[TBL] [Abstract] [Full Text] [Related]
19. Racial and Ethnic Disparities in the Incidence of Anti-NMDA Receptor Encephalitis.
Alsalek S; Schwarzmann KB; Budhathoki S; Hernandez-Lopez V; Smith JB; Li BH; Langer-Gould A
Neurol Neuroimmunol Neuroinflamm; 2024 Jul; 11(4):e200255. PubMed ID: 38728608
[TBL] [Abstract] [Full Text] [Related]
20. Fertility-sparing surgery in children and adolescents with borderline ovarian tumors: a retrospective study.
Zhao J; Wang D; Wang R; He Y; Jia C; Pan L; Ma S; Wu M; Wang W; Cheng X; Yang J; Xiang Y
J Ovarian Res; 2024 May; 17(1):96. PubMed ID: 38720349
[TBL] [Abstract] [Full Text] [Related]
[Next]